- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01673750
Body Image in Youth With HIV
This is an observational study that seeks to gather information about perceptions of body image through the use of a one-time questionnaire completed by participants at the time of study enrollment.
Effective management of Human Acquired Immune Deficiency Syndrome (AIDS) caused by the Human Immunodeficiency Virus (HIV) has become possible through the use of Highly Active Antiretroviral Treatment (HAART). As a result of more successful treatment options, HIV/AIDS has transitioned from a terminal illness to one which is treated as a chronic condition. One particular group that has been impacted tremendously by HIV in the United States is the adolescent population. As youth are living longer with HIV/AIDS, clinicians and researchers are beginning to examine ways in which the disease can affect one's physical health, mental health, and other psychosocial factors. Research emerging involving adults with HIV/AIDS has suggested that increased attention to and negative views of one's body image may be found at a higher rate in this group. To our knowledge, very few studies have examined this relationship in adolescents with HIV.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The purpose of this exploratory study is to characterize body image perceptions among youth with perinatally and behaviorally acquired HIV. In a cross-sectional design, adolescents will be asked to complete an ACASI questionnaire that will assess body image, medication adherence, depressive symptoms, medical, and other sociodemographic variables which may relate to adolescents with HIV. Information regarding the adolescents' medical history, medications, and physical functioning also will be abstracted from his or her medical record. Guided by the Intervention Mapping (IM) approach, findings from this study will inform future intervention studies designed to enhance HIV disease management among adolescents.
PRIMARY OBJECTIVE:
To characterize body image perceptions among youth with HIV.
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
Tennessee
-
Memphis, Tennessee, Vereinigte Staaten, 38105
- St. Jude Children's Research Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Diagnosis of HIV infection as documented in adolescent's medical record
- Adolescent is aware of his/her HIV diagnosis
- The adolescent/caregiver's primary language in English
- Adolescent is ≥ 16 and < 24 years old
- Adolescent is willing and able to provide consent per institutional guidelines
Exclusion Criteria:
- Adolescent has documented diagnosis of mental retardation or a significant motor or sensory impairment that would preclude participation in the study survey.
- Adolescent has known acute psychiatric illness, including suicidal ideation, homicidal ideation or active psychosis.
- Adolescent is a pregnant female.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Participants
Participants will have documented HIV infection and are aware of their diagnosis.
They will complete a one-time questionnaire.
|
The primary outcome, characterizing body image among HIV infected adolescents, will be measured using a questionnaire administered to study participants through Audio Computer Assisted Self-Interview (ACASI) technology.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Reported level of normative body image and discrepancy between perceived body image and preferred body image
Zeitfenster: Once at time of participant enrollment
|
The MBSRQ-AS is a well-validated self-report inventory for the assessment of body image (BI). It has five subscales: Appearance Evaluation, Appearance Orientation, Overweight Preoccupation, Self-Classified Weight, Body Areas Satisfaction Scale. Descriptive analyses (means and standard deviations of overall scores and means for each subscale) will be reported. The Figure Rating Scale is a culturally relevant measure modeled after Stunkard's widely used nine-figure scale of schematic figures of varying size. Participants will be asked to identify which BI they find most similar to their current body type and which BI would be ideal or preferred. A BI discrepancy (BID) score will be calculated for each subject based on their responses on the Figure Rating Scale: negative BID score indicates the subject's ideal BI is larger than perceived; positive BID score indicates the subject wants to be smaller/thinner than perceived; score of zero indicates the subject prefers his/her perceived BI. |
Once at time of participant enrollment
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Megan Wilkins, PhD, St. Jude Children's Research Hospital
Publikationen und hilfreiche Links
Nützliche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- RNA-Virusinfektionen
- Viruserkrankungen
- Infektionen
- Durch Blut übertragene Infektionen
- Übertragbare Krankheiten
- Sexuell übertragbare Krankheiten, viral
- Sexuell übertragbare Krankheiten
- Lentivirus-Infektionen
- Retroviridae-Infektionen
- Immunologische Mangelsyndrome
- Erkrankungen des Immunsystems
- Langsame Viruserkrankungen
- HIV-Infektionen
- Erworbenes Immunschwächesyndrom
Andere Studien-ID-Nummern
- HIVBI
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur HIV
-
Duke UniversityGilead SciencesRekrutierungHIV-Prävention | HIV-Präexpositionsprophylaxe | HIV-Präventionsprogramm | HIV-Prävention und -Pflege | Einsatz zur HIV-PräexpositionsprophylaxeVereinigte Staaten
-
Federal University of São PauloGilead SciencesAbgeschlossen
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRekrutierungHIV | HIV-Test | HIV-Verbindung zur Pflege | HIV-BehandlungVereinigte Staaten
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RekrutierungHIV-Prävention | PrEP-Adhärenz | HIV-bezogene StigmatisierungThailand
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RekrutierungPrEP | HIV | HIV-Prävention | PrEP-AufnahmeVereinigte Staaten
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RekrutierungDurchführbarkeit | HIV-Prävention | PrEP-Aufnahme | Annehmbarkeit | HIV-Selbsttest | Männliche Partner von HIV-negativen postpartalen FrauenSüdafrika
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)RekrutierungHIV-Prävention | HIV-Risikoverhalten | HIV-Beratung und -TestVereinigte Staaten
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationAbgeschlossenPartner-HIV-Test | HIV-Beratung für Paare | Paarkommunikation | HIV-InzidenzKamerun, Dominikanische Republik, Georgia, Indien
-
University of MinnesotaZurückgezogenHIV-Infektionen | HIV/Aids | HIV | AIDS | Aids/HIV-Problem | AIDS und InfektionenVereinigte Staaten
-
Instituto Mexicano del Seguro SocialRekrutierungGewichtsverlust | HIV | HIV-1-Infektion | Gewichtsänderung | HIV-assoziierter Gewichtsverlust | Integrase-Inhibitoren, HIV; HIV-PROTEASE-INHIBMexiko